<DOC>
	<DOCNO>NCT01086579</DOCNO>
	<brief_summary>Prospective multicentre randomize ( 1:1 ) investigator initiate study , consecutive patient undergo percutaneous revascularization small coronary vessel assign one two study arm : 1 . Treatment Arm : IN.PACT Falcon™ paclitaxel drug-eluting balloon ( DEB ) dilatation provisional spot bare-metal stenting ( BMS ) . 2 . Control Arm : paclitaxel-eluting stent ( PES ) implantation per standard practice . Eligible subject coronary artery disease small vessel ( reference diameter &lt; 2.8mm ) consecutively screen enrol base inclusion exclusion criteria The objective study ass non-inferiority DEB PES regard primary endpoint mean late lumen loss ( LLL ) 6 month , define difference postprocedural minimum luminal ( MLD ) diameter follow-up MLD , assess quantitative coronary angiography base follow assumption : 1 . The mean LLL 2 group precisely equal 2 . A standard deviation LLL 0.5mm group demonstrate ISAR-SMART 3 PEPCAD II trial 3 . A non-inferiority margin 0.25mm group clinically unimportant Based assumption : 1 . Null hypothesis ( N0 ) : mean LLL DEB group ≥0.25mm PES group ( i.e . PES superior DEB ) 2 . Alternative hypothesis 1 ( H1 ) : mean LLL DEB PES &lt; 0.25mm ( i.e . DEB non-inferior PES ) 3 . Alternative hypothesis 2 ( H2 ) : mean LLL DEB PES &lt; 0 ( i.e . DEB superior PES ) Based calculation , sample size 77 patient require group show non-inferiority DEB vs. PES α error 0.025 ( one-sided Z test ) power 80 % . To account 20 % rate withdrawal , lose follow-up present follow-up angiography , total 182 patient ( 91 group ) randomize .</brief_summary>
	<brief_title>Balloon Elution Late Loss Optimization ( BELLO ) Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Age &gt; 18 year . Patient provide write informed consent . Patients stable angina pectoris ( Canadian Cardiovascular Society [ CCS ] 1 , 2 3 ) unstable angina pectoris document ischemia ( CCS 4 , Braunwald Class IBC , IIBC IIIBC ) , patient document silent ischemia . Patients eligible coronary revascularization ( angioplasty and/or CABG ) . Female patient child bear potential must negative pregnancy test within one week treatment must use adequate contraception . Angiographic Native coronary artery . De novo lesion . Reference vessel diameter &lt; 2.8mm visual estimate . Target lesion visually estimate stenosis &gt; 50 % . Target lesion length &lt; 25mm visual estimate . A maximum 2 epicardial vessel require revascularization . A maximum 2 target lesion include ( In case treatment one lesion , treatment select remain ) . Patients unable give inform consent . Patients enrol another study investigational drug device within past 30 day . Patients scheduled major surgical intervention within 6 month enrolment study . Patients acute ( &lt; 24h ) recent ( ≤ 48 hour ) myocardial infarction . Patients contraindication emergency coronary bypass surgery . Any individual may refuse blood transfusion . Patients serum creatinine &gt; 2.0mg/dL &gt; 180umol/L . Patients severe congestive heart failure . Patients cerebral stroke &lt; 6 month prior Index Procedure . EF ( Ejection Fraction ) &lt; 30 % . Patients know allergy , hypersensitivity intolerance acetylsalicylic acid ( ASA ) , Clopidogrel Ticlopidine , Paclitaxel . Any known allergy contrast medium pretreated . Angiographic exclusion criterion : &gt; 2 epicardial vessel require revascularization . Target lesion distance ostium leave anterior descend coronary artery ( LAD ) /left circumflex coronary artery ( LCX ) /right coronary artery ( RCA ) &lt; 5 mm . Target lesion locate either venous arterial graft . Target vessel contain previously implant stent . Angiographic evidence thrombus target site . Chronic total occlusion . Restenotic lesion . Bifurcation lesion operator decide 2stent technique intentiontotreat require OR bifurcation side branch ≥ 2.5mm . Failure successfully treat nontarget lesion within target vessel ( nontarget lesion must treat prior target lesion ) . Greater 2 nontarget lesion treat index procedure . Previous Percutaneous Coronary Intervention ( PCI ) within last 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>paclitaxel PTCA drug-eluting balloon</keyword>
	<keyword>provisional spot stenting</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>Late Lumen Loss</keyword>
	<keyword>Minimal lumen diameter</keyword>
	<keyword>coronary artery disease small vessel</keyword>
</DOC>